The Scientific Committee will evaluate all the papers submitted and reserves the right to choose the time slots. Neither the name of the authors nor the origin of the study should appear in the title or text of the abstract. The scientific committee will evaluate the abstract without identification. Abstracts will have a maximum of 350 words (excluding the title, authors, affiliations and bibliographical references). Abstracts exceeding the stipulated length will be automatically rejected. No images or graphics are allowed. Abstracts must be written in English. The abstract must not contain spelling or grammatical errors, as it will be reproduced exactly as it was submitted. At the congress, oral communications must be given in English. Clinical/research case summaries should follow the following structure: Introduction and Objective, Method, Results and Conclusion. If bibliographical references are included, they must follow the Vancouver format and must not exceed a maximum of 5. In the case of pharmaceutical products, phyto preparations and food supplements, it is not permitted to include their trade name, only the name of the active ingredient or the quantitative-qualitative composition of the phyto preparation or supplement. Communications may not mention any commercial company or laboratory, nor may logos appear. Submission of a communication to the congress implies acceptance of the rules of this call. The result of the Scientific Committee’s assessment of the papers will be final. The organization may reject any paper that does not comply with any of the above rules.